Ashland ASH Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Revenue by Business | |||||
| Intermediates And Solvents | $136M-6.2% | $145M-21.6% | $185M-27.7% | $256M+43.0% | |
| Life Sciences | $641M-20.9% | $810M-6.8% | $869M+6.6% | $815M+10.6% | |
| Personal Care And Household | $578M-8.8% | $634M+6.2% | $597M-11.9% | $678M+14.3% | |
| Specialty Additives | $511M-10.7% | $572M-4.7% | $600M-16.6% | $719M+9.8% | |
| Operating Income by Business | |||||
| Intermediates And Solvents | $8M-72.4% | $29M-42.0% | $50M-42.5% | $87M+156% | |
| Personal Care And Household | $90M+25.0% | $72M+35.8% | $53M-48.0% | $102M+37.8% | |
| Specialty Additives | -$343M— | —— | —— | $102M+67.2% | |
| Unallocated And Other | -$273M-3.4% | -$264M-136% | -$112M+2.6% | -$115M-6.5% | |
| Earnings Before Interest Tax Depreciation And Amortization by Business | |||||
| Intermediates And Solvents | $20M-51.2% | $41M-33.9% | $62M-38.0% | $100M+108% | |
| Personal Care And Household | $154M+1.3% | $152M+10.1% | $138M-25.8% | $186M+20.0% | |
| Specialty Additives | -$275M-409% | $89M+4.7% | $85M-54.1% | $185M+26.7% | |
| Unallocated And Other | -$273M-3.4% | -$264M-136% | -$112M+2.6% | -$115M-7.5% | |
| Goodwill Impairment And Income Loss On Acquisitions And Divestitutres Net by Business | |||||
| Intermediates And Solvents | $0— | $0— | $0— | —— | |
| Life Sciences | $375M— | $0— | $0— | —— | |
| Personal Care And Household | $0— | $0— | $0— | —— | |
| Specialty Additives | $331M— | $0— | $0— | —— | |
| Unallocated And Other | $161M+40.0% | $115M+2,017% | -$6M— | —— | |
| Total Assets by Business | |||||
| Intermediates And Solvents | $477M-7.9% | $518M— | —— | —— | |
| Life Sciences | $6.72B-8.9% | $7.37B-4.9% | $7.75B+0.6% | $7.71B-1.4% | |
| Personal Care And Household | $2.87B-26.2% | $3.89B— | —— | —— | |
| Specialty Additives | $4.75B-22.2% | $6.1B-6.3% | $6.51B+1.3% | $6.42B-2.4% | |
| Unallocated And Other | $4.88B-8.4% | $5.33B+0.3% | $5.31B-21.3% | $6.75B+15.9% | |
| Segment Expenditure Addition To Long Lived Assets by Business | |||||
| Intermediates And Solvents | $3M+50.0% | $2M-33.3% | $3M-57.1% | $7M— | |
| Life Sciences | $49M-19.7% | $61M+32.6% | $46M+64.3% | $28M— | |
| Personal Care And Household | $7M-36.4% | $11M-45.0% | $20M+42.9% | $14M— | |
| Specialty Additives | $34M-44.3% | $61M-38.4% | $99M+62.3% | $61M— | |
| Unallocated And Other | $5M+150% | $2M0.0% | $2M-33.3% | $3M— | |
| Adjustment For Amortization by Business | |||||
| Intermediates And Solvents | $1M+200% | -$1M0.0% | -$1M-200% | $1M— | |
| Life Sciences | $19M-17.4% | $23M-20.7% | $29M+3.6% | $28M0.0% | |
| Personal Care And Household | $35M-18.6% | $43M-8.5% | $47M0.0% | $47M+11.9% | |
| Specialty Additives | $9M-25.0% | $12M-33.3% | $18M-5.3% | $19M-5.0% | |
| Depreciation by Business | |||||
| Intermediates And Solvents | $12M-7.7% | $13M0.0% | $13M+8.3% | $12M-7.7% | |
| Life Sciences | $57M+50.0% | $38M-7.3% | $41M+17.1% | $35M-2.8% | |
| Personal Care And Household | $29M-21.6% | $37M-2.6% | $38M+2.7% | $37M-5.1% | |
| Specialty Additives | $76M-30.3% | $109M+87.9% | $58M-9.4% | $64M-1.5% | |
| Goodwill Foreign Currency Translation And Other by Business | |||||
| Intermediates | $0— | $0— | $0— | $0— | |
| Life Sciences | $19M-5.0% | $20M-37.5% | $32M+146% | -$69M-1,280% | |
| Personal Care | $3M0.0% | $3M-25.0% | $4M+136% | -$11M-450% | |
| Specialty Additives | $9M-30.8% | $13M-7.1% | $14M+137% | -$38M-3,900% | |
| Goodwill by Business | |||||
| Life Sciences | $2.53B-23.2% | $3.3B-0.2% | $3.31B+0.7% | $3.28B-5.3% | |
| Specialty Additives | $1.07B-37.8% | $1.72B+0.8% | $1.7B-0.3% | $1.71B-5.2% | |
| Goodwill Impaired Accumulated Impairment Loss by Business | |||||
| Specialty Additives | $1.36B+95.1% | $696M0.0% | $696M0.0% | $696M0.0% | |
| Revenue by Geography | |||||
| Asia Pacific | $477M-8.8% | $523M+1.9% | $513M-9.8% | $569M+15.7% | |
| Europe | $663M-9.9% | $736M-5.6% | $780M-6.6% | $835M+10.4% | |
| Latin America And Other | $187M-3.1% | $193M-14.2% | $225M+5.6% | $213M+12.7% | |
| North America | $539M-24.0% | $709M-3.3% | $733M-14.0% | $852M+17.2% | |
| US | $464M-25.6% | $624M-1.6% | $634M-13.3% | $731M+14.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Ashland break its business down?
- Ashland (ASH) reports revenue by business across 4 parts — Intermediates And Solvents, Life Sciences, Personal Care And Household and Specialty Additives. Each is extracted from the segment footnotes and tracked over time.
- Where does Ashland's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Ashland's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
